Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Boku S, Satake H, Ohta T, Mitani S, Kawakami K, Suzuki Y, Matsumoto T, Terazawa T, Yamazaki E, Hasegawa H, Ikoma T, Uemura M, Yamaguchi T, Naito A, Ishizuka Y, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Tsujinaka T, Kato T, Satoh T, Kagawa Y. Boku S, et al. Among authors: kagawa y. Future Oncol. 2022 Dec;18(38):4153-4160. doi: 10.2217/fon-2022-0949. Epub 2022 Dec 8. Future Oncol. 2022. PMID: 36475784 Free article.
Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K, Haraguchi N, Kano Y, Kagawa Y, Konno M, Nishikawa S, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Fukami M, Ishii M, Yamamoto H, Doki Y, Mori M, Ishii H. Ohta K, et al. Among authors: kagawa y. Int J Oncol. 2013 Apr;42(4):1212-8. doi: 10.3892/ijo.2013.1799. Epub 2013 Jan 25. Int J Oncol. 2013. PMID: 23354547
Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.
Kano Y, Konno M, Ohta K, Haraguchi N, Nishikawa S, Kagawa Y, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Ishii M, Mizohata E, Inoue T, Mori M, Doki Y, Ishii H. Kano Y, et al. Among authors: kagawa y. Mol Clin Oncol. 2013 Jul;1(4):753-757. doi: 10.3892/mco.2013.127. Epub 2013 May 21. Mol Clin Oncol. 2013. PMID: 24649241 Free PMC article.
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R, Nishimura J, Kagawa Y, Osawa H, Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, Takemasa I, Mizushima T, Okuzaki D, Yamamoto H, Doki Y, Mori M. Nonaka R, et al. Among authors: kagawa y. Oncol Rep. 2014 Dec;32(6):2354-8. doi: 10.3892/or.2014.3515. Epub 2014 Sep 24. Oncol Rep. 2014. PMID: 25269744
RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.
Naito A, Yamamoto H, Kagawa Y, Naito Y, Okuzaki D, Otani K, Iwamoto Y, Maeda S, Kikuta J, Nishikawa K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Ishii H, Doki Y, Mori M, Ishii M. Naito A, et al. Among authors: kagawa y. J Biol Chem. 2015 Mar 6;290(10):6326-37. doi: 10.1074/jbc.M114.614859. Epub 2015 Jan 20. J Biol Chem. 2015. PMID: 25605732 Free PMC article.
[Cetuximab improved the poor performance status of a colorectal cancer patient].
Sakisaka H, Kato T, Kagawa Y, Ishida T, Sato Y, Morimoto Y, Matsushita K, Hashimoto T, Kusama H, Kimura K, Katsura Y, Nitta K, Okishiro M, Takeno A, Nakahira S, Taniguchi H, Egawa C, Takeda Y, Tamura S. Sakisaka H, et al. Among authors: kagawa y. Gan To Kagaku Ryoho. 2014 Nov;41(12):1776-8. Gan To Kagaku Ryoho. 2014. PMID: 25731326 Japanese.
[A Case of Neuroendocrine Carcinoma of the Gallbladder].
Ishida T, Ohmura Y, Takeda Y, Katsura Y, Ohneda Y, Motoyama Y, Sato Y, Morimoto Y, Kuwahara R, Naito A, Murakami K, Kagawa Y, Okishiro M, Takeno A, Egawa C, Kato T, Tamura S. Ishida T, et al. Among authors: kagawa y. Gan To Kagaku Ryoho. 2015 Nov;42(12):1746-8. Gan To Kagaku Ryoho. 2015. PMID: 26805159 Japanese.
1,152 results